Nath Bio-Genes (India) Ltd - Stock Valuation and Financial Performance

BSE: 537291 | NSE: NATHBIOGEN | Agriculture | Small Cap

Nath Bio-Genes Share Price

172.05 -3.40 -1.94%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Nath Bio-Genes

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Nath Bio-Genes (India) stock performance -

mw4me loader
P/E Ratio (SA):
7.60
Market Cap:
327 Cr.
52-wk low:
167.5
52-wk high:
264.5

Is Nath Bio-Genes (India) Ltd an attractive stock to invest in?

1. Is Nath Bio-Genes (India) Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Nath Bio-Genes (India) Ltd is a below average quality company.

2. Is Nath Bio-Genes (India) Ltd undervalued or overvalued?

The key valuation ratios of Nath Bio-Genes (India) Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Nath Bio-Genes (India) Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Nath Bio-Genes (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Nath Bio-Genes:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nath Bio-Genes (India) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 26.5%13.9%9.5%9.2%8.3%9.2%9.8%-7.8%7.1%7.3%-
Value Creation
Index
0.90.0-0.3-0.3-0.4-0.3-0.3-1.6-0.5-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 185162170192231280308278301333351
Sales YoY Gr.--12.5%4.8%12.8%20.5%21.2%9.9%-9.5%8.2%10.4%-
Adj EPS 15.88.810.115.520.126.429.3-35.518.321.122.6
YoY Gr.--44.1%14.7%52.6%30%31.5%10.9%-221.2%NA15.2%-
BVPS (₹) 66.975.8189.5246.9267.1293.4322.7285.2301.7321.3338.5
Adj Net
Profit
25.314.116.229.438.250.255.7-67.534.940.243
Cash Flow from Ops. 5.9-13.63.3-47-22.99.51.117.138.474.7-
Debt/CF from Ops. 3.8-4.322.1-0.7-2.57.490.65.52.71.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 6.7%7.6%2.7%10.4%
Adj EPS 3.3%1%-10.3%15.2%
BVPS19%3.8%-0.1%6.5%
Share Price 1.1% -11.5% -13.8% -16.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
26.812.47.67.67.89.49.5-11.76.36.86.9
Op. Profit
Mgn %
18.815.217.121.118.819.621.813.416.315.215.4
Net Profit
Mgn %
13.78.79.615.316.61818.1-24.211.612.112.3
Debt to
Equity
0.20.50.20.10.10.10.20.20.20.20
Working Cap
Days
365490500520553552572652600577653
Cash Conv.
Cycle
169262263264280271301360312297391

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 6.90%

Sales growth is good in last 4 quarters at 16.89%

Sales growth has been subdued in last 3 years 2.65%

Net Profit has been subdued in last 3 years -10.33%

Latest Financials - Nath Bio-Genes (India) Ltd.

Standalone Consolidated
TTM EPS (₹) 22.6 21
TTM Sales (₹ Cr.) 351 351
BVPS (₹.) 338.5 336.9
Reserves (₹ Cr.) 624 621
P/BV 0.51 0.51
PE 7.60 8.18
From the Market
52 Week Low / High (₹) 167.50 / 264.50
All Time Low / High (₹) 38.90 / 585.00
Market Cap (₹ Cr.) 327
Equity (₹ Cr.) 19
Face Value (₹) 10
Industry PE 44.6

Management X-Ray of Nath Bio-Genes:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *9.3416.3816.3816.3816.3816.3816.3816.3816.3816.38
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Nath Bio-Genes

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales185162170192231280308278301333
Operating Expenses 151137141151188225241241252282
Manufacturing Costs100887088144181162129112139
Material Costs-26-201210-25-41-13917-9
Employee Cost 16141412161924252327
Other Costs 6156454252676779100124
Operating Profit 35252940435567374950
Operating Profit Margin (%) 18.7%15.2%17.1%21.1%18.8%19.6%21.7%13.4%16.3%15.2%
Other Income 1111222211
Interest 56101057911109
Depreciation 4431113333
Exceptional Items 0000000-8903
Profit Before Tax 26151730394957-633642
Tax 11010-21412
Profit After Tax 25141629385056-673540
PAT Margin (%) 13.7%8.7%9.6%15.4%16.6%18.0%18.1%-24.2%11.7%12.1%
Adjusted EPS (₹)15.98.910.215.520.226.629.3-35.418.521.1
Dividend Payout Ratio (%)0%0%0%0%0%0%7%-6%11%9%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 107121303469508558613542573611
Share Capital 16161619191919191919
Reserves 91105287450489539594523554592
Minority Interest0000000000
Debt2158693258709992104107
Long Term Debt115200101103
Short Term Debt2043493257709992104104
Trade Payables52484437506835432842
Others Liabilities 453938323234426387117
Total Liabilities 225266454570648729790740793877

Fixed Assets

Gross Block6182224228250265267267270274
Accumulated Depreciation48521617181920222525
Net Fixed Assets1330207211232246247245244249
CWIP 0000000000
Investments 5555555556
Inventories117141130123155204226220208229
Trade Receivables45455282108107109869794
Cash Equivalents 2164521222943876
Others Assets444354104126145173180200223
Total Assets 225266454570648729790740793877

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 6-143-47-2391173875
PBT 26151730394957-633642
Adjustment 910131057101021310
Changes in Working Capital -28-39-26-87-64-45-65-19-1023
Tax Paid -1000-3-20-3-10
Cash Flow From Investing Activity -2-17-4-4-20-14-10-20-3-27
Capex -1-7-4-5-22-16-4-1-3-27
Net Investments 000000000-1
Others -1-100021-7-1900
Cash Flow From Financing Activity -43059020616-22-2-10
Net Proceeds from Shares 000136000000
Net Proceeds from Borrowing -1145-20000002
Interest Paid -5-6-10-10-5-7-9-11-10-9
Dividend Paid 0000000-4-4-4
Others 12210-17251225-8131
Net Cash Flow -10539-2317-253438
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)26.8912.47.677.627.879.489.51-11.666.316.79
ROCE (%)26.4913.859.59.28.289.249.78-7.827.117.34
Asset Turnover Ratio0.90.660.470.370.380.410.410.360.390.4
PAT to CFO Conversion(x)0.24-10.19-1.62-0.610.180.02N/A1.091.88
Working Capital Days
Receivable Days79102104127150140128128111105
Inventory Days202290291242220235256293259240
Payable Days-634-9051,3621,554-634-528-1,4721,663744-1,432

Nath Bio-Genes (India) Ltd Stock News

Nath Bio-Genes (India) Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Nath Bio-Genes on 21-Nov-2024 16:59 is ₹172.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Nath Bio-Genes stood at ₹327.0.
The latest P/E ratio of Nath Bio-Genes as of 21-Nov-2024 16:59 is 7.60.
The latest P/B ratio of Nath Bio-Genes as of 21-Nov-2024 16:59 is 0.51.
The 52-week high of Nath Bio-Genes is ₹264.5 and the 52-week low is ₹167.5.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nath Bio-Genes is ₹350.8 ( Cr.) .

About Nath Bio-Genes (India) Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.